Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing ...

Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease. It causes the left ventricle to thicken, the ...

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...

The Japanese biotech firm Heartseed and Danish pharmaceutical company Novo Nordisk have announced successful dosing of the first patient with their investigational cell therapy for severe heart ...

With populations aging rapidly worldwide, heart failure has become one of the most pressing medical and social challenges. Older patients face not only a high mortality risk but also losses in muscle ...